Acceptance and Commitment Therapy (ACT) - Based Treatment Development for Cancer Patients Treated for Pain
NCT ID: NCT03910296
Last Updated: 2022-05-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
10 participants
OBSERVATIONAL
2019-02-20
2021-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Novel Intervention for Patients With Cancer
NCT05643027
Acceptance and Commitment Therapy for Chronic Pain in Cancer Survivors
NCT03661840
Development of an Intervention to Enhance Cancer Pain Management
NCT03752268
Meaning-Centered Pain Coping Skills Training for Cancer Pain
NCT05385965
Meaning-Centered Pain Coping Skills Training
NCT04431830
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acceptance & Commitment Therapy
* Acceptance \& Commitment Therapy (ACT) use acceptance, mindfulness, commitment, and behavior change strategies to increase psychological flexibility.
* Each subject will participate for 6 sessions of Acceptance \& Commitment Therapy (ACT).
* ACT trains patients to reframe their unpleasant, negative, private events while encouraging personal values.
Acceptance & Commitment Therapy
ACT is a unique, third-wave therapy that uses metaphors and experiential exercises to encourage contact with previously avoided thoughts, feelings, and behaviors.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acceptance & Commitment Therapy
ACT is a unique, third-wave therapy that uses metaphors and experiential exercises to encourage contact with previously avoided thoughts, feelings, and behaviors.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* speak and comprehend English sufficiently to be able to complete the study procedures and participate in psychotherapy in English
* have been diagnosed with cancer
* have an estimated survival time ≥6 months (as approximated by palliative care clinic staff)
* score ≥4 on the Opioid Risk Tool (Webster \& Webster, 2005) with psychosocial distress as one of the positive items.
Exclusion Criteria
* untreated psychotic disorders
* untreated borderline personality disorder
* have an estimated survival time ≤6 months (as approximated by clinic staff).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dana-Farber Cancer Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
MiryamYusufov
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Miryam Yusufov, MD
Role: PRINCIPAL_INVESTIGATOR
Dana-Farber Cancer Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19-035
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.